1.
Clin Infect Dis
; 73(7): 1281-1283, 2021 10 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33987660
RESUMO
Tests for visceral leishmaniasis (VL) are not uniformly effective for all endemic regions. In a serological assay, a novel antigen, otubain cysteine peptidase, compared with rK39, showed comparable sensitivity with Indian VL serum samples and prominently increased sensitivity with Brazilian samples, as well as improved monitoring of the treatment response.